Wall Street Experts
ver. ZuMIgo(08/25)
Centessa Pharmaceuticals plc
Rachunek Zysków i Strat
Przychody TTM (mln): 7
EBIT TTM (mln): -148
index |
0 |
1 |
2 |
3 |
4 |
5 |
Rok finansowy |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
0 |
0 |
0 |
0 |
7 |
0 |
Przychód Δ r/r |
0.0% |
0.0% |
0.0% |
0.0% |
inf% |
-100.0% |
Marża brutto |
0.0% |
0.0% |
-inf% |
-inf% |
88.2% |
0.0% |
EBIT (mln) |
-5 |
-10 |
-139 |
-212 |
-172 |
-201 |
EBIT Δ r/r |
0.0% |
106.6% |
1234.4% |
52.4% |
-19.0% |
16.9% |
EBIT (%) |
0.0% |
0.0% |
0.0% |
0.0% |
-2499.4% |
nan |
Koszty finansowe (mln) |
0 |
0 |
3 |
7 |
10 |
-10 |
EBITDA (mln) |
-5 |
-10 |
-139 |
-208 |
-171 |
-201 |
EBITDA(%) |
0.0% |
0.0% |
0.0% |
0.0% |
-2487.6% |
nan |
Podatek (mln) |
0 |
0 |
0 |
-1 |
-25 |
3 |
Zysk Netto (mln) |
-5 |
-11 |
-382 |
-216 |
-152 |
-236 |
Zysk netto Δ r/r |
0.0% |
109.0% |
3358.5% |
-43.4% |
-29.8% |
55.4% |
Zysk netto (%) |
0.0% |
0.0% |
0.0% |
0.0% |
-2204.7% |
nan |
EPS |
-0.0745 |
-0.0777 |
-4.24 |
-2.31 |
-1.58 |
-2.06 |
EPS (rozwodnione) |
-0.0745 |
-0.0777 |
-4.24 |
-2.31 |
-1.58 |
-2.06 |
Ilośc akcji (mln) |
71 |
142 |
90 |
93 |
96 |
114 |
Ważona ilośc akcji (mln) |
71 |
142 |
90 |
93 |
96 |
114 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |